ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma
Medical Oncology · 07.11.2024 · 41 (12)
DOI: 10.1007/s12032-024-02483-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 07.11.2024. Verfasst von Ling Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College, Southwest Medical University, Luzhou, 646000, China. Hauptthemen laut MEDLINE: Ferroptosis, NF-E2-Related Factor 2, Esophageal Squamous Cell Carcinoma, Amino Acid Transport System y+. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Special Fund Project of the Central Government for Guiding Local Science and Technology Development of Shandong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Medical College, Southwest Medical University, Luzhou, 646000, China.
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, 250117, China.
- Clinical Medical College, Southwest Medical University, Luzhou, 646000, China. bsli@sdfmu.edu.cn.
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, 250117, China. bsli@sdfmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Special Fund Project of the Central Government for Guiding Local Science and Technology Development of Shandong Province
Zitieren
APA
Yan, L., Hu, H., Feng, L., Li, Z., Zheng, C., Zhang, J., Yin, X., & Li, B. (2024). ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma. Medical Oncology, 41(12). https://doi.org/10.1007/s12032-024-02483-6
Vancouver
Yan L, Hu H, Feng L, Li Z, Zheng C, Zhang J, et al. ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma. Medical Oncology. 2024;41(12). doi:10.1007/s12032-024-02483-6
BibTeX
@article{Yan2024,
author = {Yan, Ling and Hu, Huidong and Feng, Lei and Li, Zhe and Zheng, Chunyan and Zhang, Junpeng and Yin, Xiaoyang and Li, Baosheng},
title = {ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma},
journal = {Medical Oncology},
year = {2024},
volume = {41},
number = {12},
doi = {10.1007/s12032-024-02483-6}
}
EUVIMED